Podcast: Play in new window | Download (Duration: 33:54 — 77.6MB)
Subscribe: Apple Podcasts | Spotify | RSS
On this episode of Biotalk, Locust Walk’s Geoff Meyerson welcomes Stephen Sands, former Vice Chairman of Investment Banking and Chairman of the Global […]
Transaction Case Studies MULTI-TRACK ENGAGEMENT LEADING TO AN EQUITY INVESTMENT Situation Assessment Rapid Micro Biosystems is a privately held, commercial
Transaction Case Studies GLOBAL DEAL WITH A JAPANESE COMPANY FOR BRINCIDOFOVIR, A BROAD-SPECTRUM ANTIVIRAL FOR THE TREATMENT AND PREVENTION OF
Transaction Case Studies RAPID M&A ADVISORY Situation Assessment Anokion Bio is Swiss biotechnology company focused on autoimmune diseases by restoring
Transaction Case Studies MULTI-TRACK ENGAGEMENT LEADING TO ACQUISITION OF XYPHOS BY ASTELLAS FOR $120M UPFRONT AND $545M IN MILESTONE PAYMENTS
Transaction Case Studies SELL-SIDE ENGAGEMENT LEADING TO OPTION AGREEMENT FOR GREATER CHINESE RIGHTS TO A RAS PEPTIDE CANCER VACCINE Situation
Transaction Case Studies SELL-SIDE ENGAGEMENT LEADING TO A REVERSE MERGER BETWEEN BIOPHARMX AND TIMBER PHARMACEUTICALS Situation Assessment A wholly-owned subsidiary
Transaction Case Studies MULTI-TRACK ENGAGEMENT LEADING TO $30M EQUITY RAISE Situation Assessment Regenacy was spun-out from Acetylon Pharmaceuticals in connection with Celgene’s acquisition
Transaction Case Studies Chinese Joint Venture to Facilitate Indication Expansion Opportunity Situation Assessment Regenacy was spun-out from Acetylon Pharmaceuticals in
Transaction Case Studies MANA THERAPEUTICS: ROBUST DUAL-TRACK PROCESS TO A SUCCESSFUL $35M SERIES A FINANCING Situation Assessment Mana Therapeutics is